BUY National Aluminium Company — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
NALCO is progressing with its ₹30,000 crore brownfield smelter expansion at Anugola, aiming to increase capacity by 0.5 MTPA by 2030-31, supported by new technology licensing and a joint venture for p
BSE · Company Update·4 Nov · 2d ago
NALCO's proposed smelter expansion at Anugola is progressing with key approvals and partnerships secured.
NSE · Press Release·4 Nov · 2d ago
4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·4 Nov · 3d ago
National Aluminium Company Ltd reported its best-ever half-yearly financial results since the company's inception.
BSE · Company Update·3 Nov · 4d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on National Aluminium Company
- BUY — Axis Securities4 Nov 2026 · ~1 year · target ₹355 · Active
- BUY — Somil Mehta, Sharekhan2 Nov 2026 · ~3 months · target ₹350 · SL hit
- BUY — Ansh Jogendra Bhilwar29 Oct 2026 · ~1 year · target ₹360 · Active
- BUY — Amol Athawale, Kotak Securities16 Oct 2026 · ~3 months · target ₹340 · SL hit
- BUY — Prakash Gaba16 Oct 2026 · Same day · target ₹330 · Expired
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

